The efficacy and safety of a bioresorbable stent in the treatment of ST-elevation myocardial infarction patients

Asian J Surg. 2022 Sep;45(9):1805-1806. doi: 10.1016/j.asjsur.2022.01.007. Epub 2022 Feb 11.

Authors

Yue-Feng Li¹, Jian Chen¹, Hong-Chao Lin¹, Ping Li²

Affiliations

¹ Department of Cardiology, Yulin First People's Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, 537000, Guangxi, China.
² Department of Cardiology, Yulin First People's Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, 537000, Guangxi, China. Electronic address: liping077@outlook.com.

PMID: 35165022
DOI: 10.1016/j.asjsur.2022.01.007

No abstract available

Publication types

Letter

MeSH terms

Absorbable Implants
Everolimus
Humans
ST Elevation Myocardial Infarction* / surgery
Sirolimus
Stents
Treatment Outcome

Substances

Everolimus
Sirolimus